| Typicality: | 0.531 |
| Saliency: | 0.412 |
| often | 2 | temporal |
| for new pharmaceuticals | 2 | purpose |
| trial → be funded by → pharmaceutical companies | 15 |
| trial → be funded by → drug companies | 9 |
| trial → be funded by → pharmaceutical industry | 8 |
| trial → be funded by → the medicines company | 4 |
| trial → be funded by → the drug companies | 3 |
| negative | neutral | positive |
| 0.182 | 0.641 | 0.177 |
| Raw frequency | 39 |
| Normalized frequency | 0.412 |
| Modifier score | 0.825 |
| Perplexity | 87.815 |